In neonates, the number of protein-binding sites is limited. What is the danger of competitive medication binding?

Name: In neonates, the number of protein-binding sites is limited. What is the danger of competitive medication binding?
Brand: Quizplus
Rating: 4.9 (55 reviews)

Question

Quizplus · Accepted Answer

Kernicterus or bilirubin encephalopathy can occur in neonates due to limited protein-binding sites. When medications compete for these sites, bilirubin can be displaced, leading to an increased risk of bilirubin crossing the blood-brain barrier and causing brain damage.

In Neonates, the Number of Protein-Binding Sites Is Limited